Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART)

C Steininger, E Puchhammer-Stöckl… - Journal of Clinical …, 2006 - Elsevier
Cytomegalovirus (CMV) infection was one of the most important opportunistic infections in
HIV-infected patients before the introduction of highly active antiretroviral therapy (HAART) …

Clinical relevance of cytomegalovirus viraemia*,†

EB El Amari, C Combescure, S Yerly, A Calmy… - HIV …, 2011 - Wiley Online Library
Background Using new sensitive quantitative polymerase chain reaction (PCR) assays,
cytomegalovirus (CMV) DNA is often detectable in the plasma of immunosuppressed …

Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS …

A Erice, C Tierney, M Hirsch… - Clinical infectious …, 2003 - academic.oup.com
We undertook a prospective study to analyze cytomegalovirus (CMV) end-organ disease
(EOD) in subjects with advanced human immunodeficiency virus (HIV) infection. Of 403 …

Cytomegalovirus (CMV) Viremia and the CD4+ Lymphocyte Count as Predictors of CMV Disease in Patients Infected with Human Immunodeficiency Virus

L Gerard, C Leport, P Flandre, N Houhou… - Clinical infectious …, 1997 - academic.oup.com
We screened 192 patients infected with human immunodeficiency virus (HIV) to examine the
relation between CD4+ lymphocyte counts and cytomegalovirus (CMV) viremia and the …

Seroepidemiology of cytomegalovirus in patients with advanced HIV disease: influence on disease expression and survival

DH Shepp, JE Moses, MH Kaplan - JAIDS Journal of Acquired …, 1996 - journals.lww.com
To determine the prevalence and effect of cytomegalovirus (CMV) co-infection on clinical
outcome, the seroepidemiology of CMV was examined in 196 demographically diverse …

Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active …

D Salmon-Céron, MC Mazeron, S Chaput, N Boukli… - Aids, 2000 - journals.lww.com
Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4... : AIDS Plasma
cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for …

Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test

KK Dodt, PH Jacobsen, B Hofmann, C Meyer… - Aids, 1997 - journals.lww.com
Objective: Cytomegalovirus (CMV) is a frequent opportunistic viral pathogen in patients with
AIDS leading to retinitis and other serious manifestations. CMV disease may be successfully …

Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS

SA Spector, K Hsia, M Crager, M Pilcher… - Journal of …, 1999 - Am Soc Microbiol
The impact of cytomegalovirus (CMV) on human immunodeficiency virus type 1 (HIV-1)
disease progression has been controversial. In this study, we sought to determine if CMV …

Quantitation of cytomegalovirus: methodologic aspects and clinical applications

M Boeckh, G Boivin - Clinical microbiology reviews, 1998 - Am Soc Microbiol
Cytomegalovirus (CMV) is an important pathogen in transplant recipients and human
immunodeficiency virus (HIV)-infected individuals. Major progress has been made in …

Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy

JR Deayton, CA Sabin, MA Johnson, VC Emery… - The Lancet, 2004 - thelancet.com
Background Before highly active antiretroviral therapy (HAART) became available,
cytomegalovirus was a major cause of opportunistic infection in HIV-infected patients and …